Toronto, Ontario – January 10th, 2019 — PRESS RELEASE — Braingrid Limited, a global provider of sensor platforms for precision agriculture, has announced the first commercial deployment of its innovative, self-powered Sentroller S precision agriculture technology at Canadian licensed producer WeedMD Inc.’s modern greenhouse facility located in Strathroy, Ontario.

“As an innovative producer of medical-grade cannabis, we’re a long-time partner of Braingrid, starting with our best-in-class indoor cultivation facility in Aylmer, Ontario,” said Keith Merker, CEO of WeedMD. “We are finalizing a production capacity expansion at our 610,000-square-foot, state-of-the-art greenhouse in Strathroy, Ontario–incorporating the latest advancements for precision cultivation including Braingrid’s innovative technologies. We’re very pleased with the results so far with over 110,000 square feet of production space progressively online.”

Sentroller S brings the features of Braingrid’s original Sentroller platform to cultivators including a quick installation, online dashboards and reports, as well as email alarm notifications. This allows growers the peace of mind that their cannabis crops are safe and thriving. The self-powered Sentroller S uses a solar panel that enables an even quicker install and limitless possibilities for sensor placement. This wireless freedom helps cultivators monitor growing conditions in and around the plant canopy where power connections are not often available.

The new self-powered Sentroller differentiates Braingrid from the competition by monitoring mission critical cultivation parameters (i.e. temperature, relative humidity, CO2, PAR, EC, moisture) in the plant canopy, without power cords or the need to change batteries. Any form of grow lighting including LED is sufficient to power the ultra-low energy Sentroller S.

“We are very excited to have WeedMD, one of the most innovative cultivators in the cannabis sector, deploy our Sentroller S precision agriculture technology” said Michael Kadonoff, founder and CEO of Braingrid.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, and these securities will not be offered or sold in any jurisdiction in which their offer or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the 1933 Act), or any state securities laws of the United States. Accordingly, these securities will not be offered or sold to persons within the United States unless an exemption from the registration requirements of the 1933 Act and applicable state securities laws is available.